4.8 Article

Oral delivery of RNase P ribozymes by Salmonella inhibits viral infection in mice

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Salmonella-mediated delivery of RNase P-based ribozymes for inhibition of viral gene expression and replication in human cells

Yong Bai et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Review Multidisciplinary Sciences

The promises and pitfalls of RNA-interference-based therapeutics

Daniela Castanotto et al.

NATURE (2009)

Editorial Material Medicine, General & Internal

Typhoid Vaccines Ready for Implementation

Myron M. Levine

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Review Oncology

Bacterial gene therapy strategies

G Vassaux et al.

JOURNAL OF PATHOLOGY (2006)

Review Biotechnology & Applied Microbiology

Therapeutic potential of Toll-like receptor 9 activation

Arthur M. Krieg

NATURE REVIEWS DRUG DISCOVERY (2006)

Review Immunology

Toll-like receptor signalling

S Akira et al.

NATURE REVIEWS IMMUNOLOGY (2004)

Review Biotechnology & Applied Microbiology

Approaches for the sequence-specific knockdown of mRNA

LJ Scherer et al.

NATURE BIOTECHNOLOGY (2003)

Article Multidisciplinary Sciences

Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli

P Trang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)